Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prosthesis-Related Infections | 13 | 2021 | 215 | 1.270 |
Why?
|
| Arthroplasty, Replacement, Knee | 19 | 2021 | 696 | 1.250 |
Why?
|
| Arthroplasty, Replacement, Hip | 22 | 2021 | 857 | 1.230 |
Why?
|
| Pain, Postoperative | 12 | 2019 | 318 | 0.950 |
Why?
|
| Hip Prosthesis | 10 | 2019 | 569 | 0.760 |
Why?
|
| Surgical Wound Infection | 4 | 2022 | 98 | 0.550 |
Why?
|
| Prosthesis Failure | 10 | 2019 | 530 | 0.530 |
Why?
|
| Synovial Fluid | 7 | 2016 | 124 | 0.520 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 744 | 0.470 |
Why?
|
| Anesthetics, Local | 4 | 2016 | 92 | 0.470 |
Why?
|
| Middle Aged | 40 | 2020 | 9960 | 0.460 |
Why?
|
| Analgesics | 4 | 2018 | 108 | 0.460 |
Why?
|
| Male | 47 | 2020 | 15850 | 0.450 |
Why?
|
| Anti-Bacterial Agents | 5 | 2021 | 401 | 0.440 |
Why?
|
| Female | 45 | 2020 | 16410 | 0.430 |
Why?
|
| Pain Measurement | 11 | 2017 | 468 | 0.420 |
Why?
|
| Dexamethasone | 3 | 2016 | 48 | 0.410 |
Why?
|
| Bupivacaine | 3 | 2016 | 54 | 0.400 |
Why?
|
| Aged | 36 | 2020 | 9620 | 0.400 |
Why?
|
| Reoperation | 18 | 2021 | 927 | 0.390 |
Why?
|
| Hip Joint | 7 | 2014 | 357 | 0.370 |
Why?
|
| Treatment Outcome | 22 | 2021 | 3561 | 0.360 |
Why?
|
| C-Reactive Protein | 7 | 2016 | 125 | 0.360 |
Why?
|
| Knee Joint | 6 | 2020 | 800 | 0.360 |
Why?
|
| Nerve Block | 3 | 2017 | 62 | 0.350 |
Why?
|
| Hip Dislocation | 4 | 2015 | 64 | 0.340 |
Why?
|
| Periprosthetic Fractures | 3 | 2016 | 32 | 0.340 |
Why?
|
| Pain Management | 4 | 2018 | 144 | 0.330 |
Why?
|
| Adult | 27 | 2017 | 8741 | 0.330 |
Why?
|
| Humans | 49 | 2021 | 29811 | 0.330 |
Why?
|
| Complex Regional Pain Syndromes | 2 | 2020 | 25 | 0.320 |
Why?
|
| Analgesia, Epidural | 3 | 2018 | 60 | 0.310 |
Why?
|
| Ketamine | 2 | 2019 | 33 | 0.310 |
Why?
|
| Pain, Intractable | 1 | 2007 | 15 | 0.300 |
Why?
|
| Terrorism | 1 | 2007 | 13 | 0.300 |
Why?
|
| Knee Prosthesis | 4 | 2020 | 244 | 0.290 |
Why?
|
| Ketorolac | 2 | 2016 | 16 | 0.280 |
Why?
|
| Motor Activity | 4 | 2017 | 372 | 0.270 |
Why?
|
| Postoperative Hemorrhage | 2 | 2017 | 25 | 0.270 |
Why?
|
| Antifibrinolytic Agents | 2 | 2017 | 23 | 0.270 |
Why?
|
| Analgesics, Opioid | 4 | 2017 | 221 | 0.270 |
Why?
|
| Tranexamic Acid | 2 | 2017 | 23 | 0.270 |
Why?
|
| Depressive Disorder | 1 | 2007 | 191 | 0.270 |
Why?
|
| Femur | 4 | 2019 | 393 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 101 | 0.260 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 80 | 0.260 |
Why?
|
| Aged, 80 and over | 18 | 2016 | 4930 | 0.260 |
Why?
|
| Neurotic Disorders | 1 | 2005 | 19 | 0.250 |
Why?
|
| Arousal | 1 | 2005 | 44 | 0.250 |
Why?
|
| Fear | 1 | 2005 | 47 | 0.250 |
Why?
|
| Analgesia | 3 | 2016 | 38 | 0.250 |
Why?
|
| Retrospective Studies | 16 | 2021 | 3325 | 0.250 |
Why?
|
| Models, Psychological | 1 | 2005 | 67 | 0.250 |
Why?
|
| Attitude to Health | 1 | 2005 | 98 | 0.240 |
Why?
|
| Sciatic Nerve | 2 | 2016 | 32 | 0.230 |
Why?
|
| Low Back Pain | 1 | 2005 | 139 | 0.230 |
Why?
|
| Arthritis, Infectious | 2 | 2016 | 58 | 0.220 |
Why?
|
| Animals | 11 | 2022 | 4637 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2015 | 29 | 0.220 |
Why?
|
| Bone Resorption | 2 | 2014 | 95 | 0.210 |
Why?
|
| Time Factors | 10 | 2016 | 1641 | 0.210 |
Why?
|
| Immunologic Factors | 1 | 2022 | 39 | 0.200 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2016 | 39 | 0.200 |
Why?
|
| Pseudomonas Infections | 1 | 2022 | 60 | 0.190 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2022 | 79 | 0.190 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 2 | 2014 | 235 | 0.190 |
Why?
|
| Joint Instability | 3 | 2014 | 389 | 0.190 |
Why?
|
| Prospective Studies | 10 | 2016 | 1823 | 0.190 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2011 | 49 | 0.180 |
Why?
|
| Risk Factors | 10 | 2019 | 2465 | 0.180 |
Why?
|
| Mice | 6 | 2022 | 1628 | 0.180 |
Why?
|
| Shoulder Joint | 2 | 2017 | 577 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2018 | 463 | 0.180 |
Why?
|
| Blood Sedimentation | 6 | 2016 | 64 | 0.180 |
Why?
|
| Edema | 1 | 2020 | 39 | 0.170 |
Why?
|
| Metformin | 1 | 2020 | 23 | 0.170 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 33 | 0.170 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2019 | 15 | 0.170 |
Why?
|
| Hypoglycemic Agents | 2 | 2020 | 57 | 0.160 |
Why?
|
| Neuralgia | 1 | 2019 | 15 | 0.160 |
Why?
|
| Clonidine | 2 | 2016 | 31 | 0.160 |
Why?
|
| Acetabulum | 2 | 2012 | 198 | 0.160 |
Why?
|
| Shoulder Dislocation | 2 | 2017 | 94 | 0.160 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 47 | 0.160 |
Why?
|
| Vancomycin | 1 | 2018 | 58 | 0.160 |
Why?
|
| Prosthesis Design | 2 | 2019 | 494 | 0.160 |
Why?
|
| Acute Pain | 1 | 2018 | 21 | 0.150 |
Why?
|
| Leukocyte Count | 5 | 2016 | 92 | 0.150 |
Why?
|
| Random Allocation | 4 | 2020 | 143 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 435 | 0.140 |
Why?
|
| Patient Satisfaction | 3 | 2017 | 297 | 0.140 |
Why?
|
| Laparotomy | 1 | 2016 | 22 | 0.140 |
Why?
|
| Administration, Oral | 4 | 2018 | 144 | 0.140 |
Why?
|
| Buprenorphine | 1 | 2016 | 5 | 0.140 |
Why?
|
| Pain Threshold | 1 | 2016 | 22 | 0.140 |
Why?
|
| Foreign-Body Reaction | 1 | 2016 | 28 | 0.140 |
Why?
|
| Range of Motion, Articular | 4 | 2020 | 707 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2016 | 69 | 0.130 |
Why?
|
| Joints | 1 | 2016 | 99 | 0.130 |
Why?
|
| Morphine | 1 | 2016 | 83 | 0.130 |
Why?
|
| Hemoglobins | 1 | 2016 | 83 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 3 | 2014 | 382 | 0.130 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2014 | 276 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 28 | 0.130 |
Why?
|
| Femur Head | 1 | 2015 | 65 | 0.120 |
Why?
|
| Nutritional Status | 1 | 2015 | 39 | 0.120 |
Why?
|
| Arthralgia | 1 | 2016 | 122 | 0.120 |
Why?
|
| Malnutrition | 1 | 2015 | 19 | 0.120 |
Why?
|
| General Surgery | 1 | 2015 | 49 | 0.120 |
Why?
|
| Insulin | 1 | 2015 | 92 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2015 | 112 | 0.120 |
Why?
|
| Metal-on-Metal Joint Prostheses | 1 | 2015 | 53 | 0.120 |
Why?
|
| Anesthesia, Epidural | 2 | 2011 | 25 | 0.120 |
Why?
|
| Rotator Cuff Injuries | 1 | 2017 | 280 | 0.120 |
Why?
|
| Joint Prosthesis | 1 | 2015 | 80 | 0.120 |
Why?
|
| Observer Variation | 1 | 2014 | 119 | 0.110 |
Why?
|
| Double-Blind Method | 5 | 2017 | 522 | 0.110 |
Why?
|
| Microbiological Techniques | 1 | 2013 | 9 | 0.110 |
Why?
|
| ROC Curve | 4 | 2016 | 140 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 1126 | 0.110 |
Why?
|
| Drainage | 1 | 2013 | 50 | 0.110 |
Why?
|
| Sepsis | 1 | 2015 | 147 | 0.110 |
Why?
|
| Arthroplasty, Replacement | 1 | 2015 | 149 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 176 | 0.110 |
Why?
|
| Arthroplasty | 1 | 2014 | 138 | 0.110 |
Why?
|
| Pelvic Bones | 1 | 2012 | 20 | 0.110 |
Why?
|
| Incidence | 4 | 2017 | 759 | 0.110 |
Why?
|
| Osteotomy | 1 | 2014 | 164 | 0.110 |
Why?
|
| Sutures | 1 | 2012 | 42 | 0.100 |
Why?
|
| Triage | 1 | 2012 | 23 | 0.100 |
Why?
|
| Braces | 1 | 2012 | 26 | 0.100 |
Why?
|
| Femoral Fractures | 1 | 2012 | 42 | 0.100 |
Why?
|
| Sex Factors | 3 | 2012 | 497 | 0.100 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2011 | 15 | 0.100 |
Why?
|
| Substance P | 1 | 2011 | 18 | 0.100 |
Why?
|
| Norepinephrine | 1 | 2011 | 21 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2011 | 32 | 0.100 |
Why?
|
| Causality | 2 | 2011 | 52 | 0.100 |
Why?
|
| Povidone-Iodine | 1 | 2011 | 8 | 0.100 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 1859 | 0.100 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 532 | 0.100 |
Why?
|
| International Normalized Ratio | 1 | 2011 | 23 | 0.100 |
Why?
|
| Joint Diseases | 1 | 2012 | 111 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2011 | 106 | 0.100 |
Why?
|
| Knee Injuries | 1 | 2014 | 228 | 0.100 |
Why?
|
| Catheterization | 1 | 2011 | 51 | 0.100 |
Why?
|
| Warfarin | 1 | 2011 | 38 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2011 | 52 | 0.090 |
Why?
|
| Patient Selection | 1 | 2012 | 234 | 0.090 |
Why?
|
| Awards and Prizes | 3 | 2017 | 25 | 0.090 |
Why?
|
| Injections | 3 | 2016 | 59 | 0.090 |
Why?
|
| Biomarkers | 4 | 2015 | 704 | 0.090 |
Why?
|
| Diabetic Neuropathies | 1 | 2010 | 14 | 0.090 |
Why?
|
| Amides | 1 | 2010 | 21 | 0.090 |
Why?
|
| Lidocaine | 1 | 2010 | 43 | 0.090 |
Why?
|
| Postoperative Complications | 5 | 2017 | 957 | 0.090 |
Why?
|
| Drug Administration Schedule | 3 | 2016 | 232 | 0.090 |
Why?
|
| Logistic Models | 3 | 2016 | 410 | 0.090 |
Why?
|
| Chronic Disease | 3 | 2009 | 508 | 0.090 |
Why?
|
| Chicago | 4 | 2015 | 866 | 0.080 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2008 | 15 | 0.080 |
Why?
|
| Dexmedetomidine | 1 | 2008 | 4 | 0.080 |
Why?
|
| Craniotomy | 1 | 2008 | 24 | 0.080 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2008 | 17 | 0.080 |
Why?
|
| Pain | 2 | 2018 | 397 | 0.080 |
Why?
|
| Heart Rate | 1 | 2008 | 152 | 0.080 |
Why?
|
| United States | 4 | 2017 | 2344 | 0.080 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2007 | 11 | 0.070 |
Why?
|
| Young Adult | 4 | 2015 | 1966 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2008 | 252 | 0.070 |
Why?
|
| Recovery of Function | 3 | 2017 | 291 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 558 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2013 | 1952 | 0.070 |
Why?
|
| Administration, Intravenous | 2 | 2017 | 28 | 0.070 |
Why?
|
| Drug Combinations | 2 | 2016 | 82 | 0.070 |
Why?
|
| Radiography | 3 | 2014 | 678 | 0.070 |
Why?
|
| Health Care Surveys | 2 | 2017 | 67 | 0.070 |
Why?
|
| Prevalence | 3 | 2012 | 494 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2019 | 286 | 0.070 |
Why?
|
| Dinoprostone | 1 | 2006 | 26 | 0.070 |
Why?
|
| Disability Evaluation | 2 | 2005 | 327 | 0.070 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 169 | 0.070 |
Why?
|
| Interleukins | 1 | 2006 | 37 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2006 | 56 | 0.070 |
Why?
|
| Behavior, Animal | 2 | 2016 | 107 | 0.070 |
Why?
|
| Walking | 2 | 2018 | 255 | 0.060 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2017 | 77 | 0.060 |
Why?
|
| Personality Assessment | 1 | 2005 | 40 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 78 | 0.060 |
Why?
|
| Metals | 2 | 2016 | 149 | 0.060 |
Why?
|
| Perioperative Period | 2 | 2017 | 12 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 190 | 0.060 |
Why?
|
| Age Distribution | 2 | 2015 | 95 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2015 | 86 | 0.060 |
Why?
|
| Wound Closure Techniques | 2 | 2016 | 9 | 0.060 |
Why?
|
| Interpersonal Relations | 1 | 2005 | 105 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2005 | 298 | 0.060 |
Why?
|
| Arthroscopy | 3 | 2017 | 817 | 0.060 |
Why?
|
| Area Under Curve | 2 | 2014 | 67 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2005 | 142 | 0.060 |
Why?
|
| Lactones | 1 | 2003 | 14 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2003 | 54 | 0.060 |
Why?
|
| Recurrence | 2 | 2017 | 354 | 0.060 |
Why?
|
| Operative Time | 2 | 2014 | 81 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 1270 | 0.050 |
Why?
|
| Rats | 2 | 2018 | 876 | 0.050 |
Why?
|
| Early Diagnosis | 2 | 2014 | 66 | 0.050 |
Why?
|
| Acute Disease | 2 | 2015 | 225 | 0.050 |
Why?
|
| Drug Evaluation | 1 | 2022 | 56 | 0.050 |
Why?
|
| Anterior Cruciate Ligament Injuries | 2 | 2014 | 262 | 0.050 |
Why?
|
| Blood Loss, Surgical | 2 | 2017 | 66 | 0.050 |
Why?
|
| Pregabalin | 2 | 2011 | 22 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2022 | 309 | 0.050 |
Why?
|
| Activities of Daily Living | 2 | 2015 | 507 | 0.050 |
Why?
|
| Tibial Fractures | 1 | 2020 | 13 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2005 | 1187 | 0.040 |
Why?
|
| Prognosis | 2 | 2012 | 874 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 969 | 0.040 |
Why?
|
| Rodentia | 1 | 2018 | 6 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2018 | 53 | 0.040 |
Why?
|
| Analgesia, Patient-Controlled | 2 | 2011 | 29 | 0.040 |
Why?
|
| Femoral Nerve | 1 | 2018 | 9 | 0.040 |
Why?
|
| Thigh | 1 | 2017 | 35 | 0.040 |
Why?
|
| Anesthesia, Conduction | 1 | 2017 | 30 | 0.040 |
Why?
|
| Adolescent | 2 | 2014 | 2332 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 58 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 2017 | 45 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2018 | 403 | 0.040 |
Why?
|
| Vasculitis | 1 | 2016 | 32 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2017 | 64 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2016 | 18 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 286 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 128 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 58 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 331 | 0.030 |
Why?
|
| Cost Savings | 1 | 2016 | 35 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 245 | 0.030 |
Why?
|
| Streptozocin | 1 | 2015 | 6 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 118 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2015 | 16 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2006 | 32 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2015 | 31 | 0.030 |
Why?
|
| Rotator Cuff | 1 | 2017 | 266 | 0.030 |
Why?
|
| Corrosion | 1 | 2015 | 129 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 23 | 0.030 |
Why?
|
| Polyethylene | 1 | 2015 | 119 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 214 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2014 | 37 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 96 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 332 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 42 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2013 | 22 | 0.030 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2014 | 89 | 0.030 |
Why?
|
| Medicaid | 1 | 2013 | 37 | 0.030 |
Why?
|
| Tantalum | 1 | 2012 | 34 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2013 | 71 | 0.030 |
Why?
|
| Menisci, Tibial | 1 | 2014 | 172 | 0.030 |
Why?
|
| Medicare | 1 | 2013 | 123 | 0.030 |
Why?
|
| Osteoarthritis, Hip | 1 | 2013 | 96 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 13 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 143 | 0.030 |
Why?
|
| Hospitalization | 1 | 2015 | 319 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 355 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 105 | 0.030 |
Why?
|
| Disease Management | 1 | 2013 | 122 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 2011 | 27 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 802 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 400 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2011 | 26 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 2011 | 66 | 0.020 |
Why?
|
| Philadelphia | 1 | 2011 | 5 | 0.020 |
Why?
|
| Suction | 1 | 2011 | 41 | 0.020 |
Why?
|
| Tibia | 1 | 2013 | 266 | 0.020 |
Why?
|
| Adrenergic Agonists | 1 | 2010 | 5 | 0.020 |
Why?
|
| Sensation | 1 | 2010 | 17 | 0.020 |
Why?
|
| Epinephrine | 1 | 2010 | 36 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 55 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 334 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2009 | 36 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 853 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 683 | 0.020 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2008 | 5 | 0.020 |
Why?
|
| Methyl Ethers | 1 | 2008 | 6 | 0.020 |
Why?
|
| Anesthetics, Inhalation | 1 | 2008 | 11 | 0.020 |
Why?
|
| Length of Stay | 1 | 2010 | 320 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2008 | 142 | 0.020 |
Why?
|
| Sleep | 1 | 2009 | 318 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2006 | 32 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2006 | 79 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2006 | 109 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2006 | 173 | 0.020 |
Why?
|
| Dyssomnias | 1 | 2003 | 8 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 350 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 28 | 0.010 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2003 | 18 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 33 | 0.010 |
Why?
|
| Sulfones | 1 | 2003 | 25 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2003 | 53 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 177 | 0.010 |
Why?
|
| Depression | 1 | 2005 | 472 | 0.010 |
Why?
|